Teva Pharmaceuticals USA, Inc. vs Allergan, Inc.

Trial Instituted Document

Exhibit 3001

Patent Owner's Power of Attorney

Patent Owner's Mandatory Notice

Notice of Accord Filing Date

Curriculum Vitae of Dr. Mansoor Amiji

File history of U.S. Patent No. 9,248,191 to Acheampong et al. Part 3

File history of U.S. Patent No. 9,248,191 to Acheampong et al. Part 5

U.S. Patent No. 9,248,191 to Acheampong et al.

Declaration of Dr. Mansoor Amiji

File history of U.S. Patent No. 9,248,191 to Acheampong et al.

File history of U.S. Patent No. 9,248,191 to Acheampong et al. Part 2

File history of U.S. Patent No. 9,248,191 to Acheampong et al. Part 4

File history of U.S. Patent Application No. 10/927,857, filed on August 27, 2010 to Acheampong et al.

File history of U.S. Patent Application No. 10/927,857, filed on August 27, 2010 to Acheampong et al. Part 3

U.S. Patent No. 5,474,979 to Ding et al., filed May 17, 1994

A. Acheampong et al., Cyclosporine distribution into the conjunctiva, cornea, lacrimal gland, and systemic blood following topical dosing of cyclosporine to rabbit, dog, and human eyes, 2 LACRIMAL GLAND, TEAR FILM, AND DRY EYE SYNDROMES 1001 (1998)

U.S. Patent No. 5,578,586 to Glonek et al., filed February 4, 1994

R. Kaswan, Intraocular Penetration of Topically Applied Cyclosporine 20 TRANSPL. PROC. 650 (1988)

K. Sall, et al., Two Multicenter, Randomized Studies of the Efficacy and Safety of Cyclosporine Ophthalmic Emulsion in Moderate to Severe Dry Eye Disease, 107 OPHTHALMOLOGY 631 (2000)

U.S. Patent No. 5,981,607 to Ding et al., filed January 20, 1998

A. Kanpolat et al., Penetration of Cyclosporin A into the Rabbit Cornea and Aqueous Humor after Topical Drop and Collagen Shield Administration 20 CLAO J 119 (1994)

A. Vieira et al., Effect of ricinoleic acid in acute and subchronic experimental models of inflammation, 9 MED. INFLAMM. 223 (2000)

D. Small et al., Blood concentrations of Cyclosporin A During Long-Term Treatment with Cyclosporin A Ophthalmic Emulsions in Patients with Moderate to Severe Dry Eye Disease 18 J. OC. PHARM. THERAP. 411 (2002)

File history of U.S. Patent No. 8,685,930 to Acheampong et al.

File history of U.S. Patent No. 8,629,111 to Acheampong et al. Part 2

File history of U.S. Patent No. 8,629,111 to Acheampong et al. Part 4

K. Kunert et al., Analysis of Topical Cyclosporine Treatment of Patients with Dry Eye Syndrome 118 ARCH OPHTHALMOL 1489 (2000)

Physicians¿¿¿ Desk Reference for Ophthalmic Medicines, 1999

K. Turner et al., Interleukin-6 Levels in the Conjunctival Epithelium of Patients with Dry Eye Disease Treated with Cyclosporine Ophthalmic Emulsion 19 CORNEA 492 (2000)

D. Stevenson et al. Efficacy and Safety of Cyclosporin A Ophthalmic Emulsion in the Treatment of Moderate-to-Severe Dry Eye Disease 107 OPHTHALMOL. 967 (2000)

REMINGTON¿¿¿S 20TH EDITION: THE SCIENCE AND PRACTICE OF PHARMACY (A. Gennaro ed. 2003)

E. Goto et al. Low-Concentration Homogenized Castor Oil Eye Drops for Noninflamed Obstructive Meibomian Gland Dysfunction 109 OPHTHALMOL. 2030 (2002)

R. Murphy, The Once and Future Treatment of Dry Eye, REVIEW OF OPTOMETRY 1 (2000)

STEDMAN¿¿¿S MEDICAL DICTIONARY 27TH EDITION (M.B. Pugh ed. 2000)

File history of U.S. Patent No. 8,629,111 to Acheampong et al.

File history of U.S. Patent No. 8,629,111 to Acheampong et al. Part 3

Complaint; Allergan, Inc. v. Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., Apotex, Inc., Apotex Corp., Akorn, Inc., Mylan Pharmaceuticals Inc., and Mylan Inc., No. 2:15-cv-01455

Curriculum Vitae of Dr. Walter Chambliss

Power of Attorney

Petitioner Exhibit List

Motion for Joinder

Petition

DECLARATION OF WALTER G. CHAMBLISS, PH.D.

File history of U.S. Patent Application No. 10/927,857, filed on August 27, 2010 to Acheampong et al. Part 2